entertainment -WSS

entertainment

author：Wikipedia 2025-08-24 23:10:02 - browse：7951

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Medicare has a new plan to address drug shortages

entertainment

WSS

FDA approves RSV monoclonal antibody for infants, toddlers

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Biden tests positive for Covid

Headspace, Meta partner to launch VR meditation app for Quest

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

focus

entertainment

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

STAT Virtual Event: The State of Biosimilars: What to Watch

United colonoscopy coverage change 'may cost lives,' doctors say

IVF, abortion rights issues kick off Biden’s State of the Union

Moonlake's readout produced a cash windfall. Risks remain

Biden tests positive for Covid

Peter Hotez and the public health issue of online harassment

FDA approves RSV monoclonal antibody for infants, toddlers

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT Virtual Event: The State of Biosimilars: What to Watch

explore

The Readout: Amylyx, Alumis, and Lundbeck drug updates

How to bring more disabled researchers into academia

Listen: Wegovy in the brain & pivotal Alzheimer's data

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Medicare to cover more brain scans for Alzheimer’s patients

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

knowledge

entertainment

knowledge

hotspot